Last Updated on June 22, 2023

Targeted Oncology- Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details


Published By: Springer Paris

Abbreviation: Target. Oncol.




Impact Score

The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

4.79

SJR

 1.460

h-Index

 55

Rank

 2248

Important Details

Title Targeted Oncology
Standard Abbreviation Target. Oncol.
Type of Publication Journal
Discipline Oncology (Q1); Pharmacology (medical) (Q1); Cancer Research (Q2)
Impact Score 4.79
SCImago Journal Rank (SJR) 1.460
h-index 55
Overall Rank 2248
Publisher Name Springer Paris
Publication Country France
International Standard Serial Number (ISSN) 1776260X, 17762596
Coverage and History 2006-2022
Best Quartile Q1
Total Citations Received
(Last 3 Year)
1042

About Targeted Oncology


Targeted Oncology is a journal published by Springer Paris. This journal covers the area[s] related to Oncology, Pharmacology (medical), Cancer Research, etc. The coverage history of this journal is as follows: 2006-2022. The rank of this journal is 2248. This journal's impact score, h-index, and SJR are 4.79, 55, and 1.460, respectively. The ISSN of this journal is/are as follows: 1776260X, 17762596.

The best quartile of Targeted Oncology is Q1. This journal has received a total of 1042 citations during the last three years (Preceding 2022).


Targeted Oncology Impact Score 2022-2023


The latest impact score (IS) of the Targeted Oncology is 4.79. It is computed in the year 2023 as per its definition and based on Scopus data. 4.79

It is increased by a factor of around 0.14, and the percentage change is 3.01% compared to the preceding year 2021, indicating a rising trend.

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Prediction of Targeted Oncology Impact Score 2023


Impact Score 2022 of Targeted Oncology is 4.79. If a similar upward trend continues, IS may increase in 2023 as well.


Impact Score Graph


Check below the Impact Score trends of Targeted Oncology. This is based on Scopus data.


Year Impact Score (IS)
2023/2024 Coming Soon
2022 4.79
2021 4.65
2020 3.91
2019 3.89
2018 3.73
2017 3.68
2016 3.03
2015 2.89
2014 3.73

Targeted Oncology h-index


  Table Setting

The h-index of Targeted Oncology is 55. By definition of the h-index, this journal has at least 55 published articles with more than 55 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.




Targeted Oncology ISSN


The International Standard Serial Number (ISSN) of Targeted Oncology is/are as follows: 1776260X, 17762596.

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Table Setting

Targeted Oncology Ranking and SCImago Journal Rank (SJR)


The Targeted Oncology is ranked 2248 among 27955 Journals, Conferences, and Book Series. As per SJR, this journal is ranked 1.460.

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.


Targeted Oncology Publisher


Table Setting

The publisher of Targeted Oncology is Springer Paris. The publishing house of this journal is located in the France. Its coverage history is as follows: 2006-2022.


Call For Papers (CFPs)


Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).


Abbreviation


The International Organization for Standardization 4 (ISO 4) abbreviation of Targeted Oncology is Target. Oncol.. ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Target. Oncol.') can be used for citing, indexing, abstraction, and referencing purposes.


How to publish in Targeted Oncology


If your area of research or discipline is related to Oncology, Pharmacology (medical), Cancer Research, etc., please check the journal's official website to understand the complete publication process.


Acceptance Rate


There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:

  • Interest/demand of researchers/scientists for publishing in a specific journal/conference.
  • The complexity of the peer review process and timeline.
  • Time taken from draft submission to final publication.
  • Number of submissions received and acceptance slots
  • And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.



Frequently Asked Questions (FAQ)


What is the impact score of Targeted Oncology?

The latest impact score of Targeted Oncology is 4.79. It is computed in the year 2023.


What is the h-index of Targeted Oncology?

The latest h-index of Targeted Oncology is 55. It is evaluated in the year 2023.


What is the SCImago Journal Rank (SJR) of Targeted Oncology?

The latest SCImago Journal Rank (SJR) of Targeted Oncology is 1.460. It is calculated in the year 2023.


What is the ranking of Targeted Oncology?

The latest ranking of Targeted Oncology is 2248. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.


Who is the publisher of Targeted Oncology?

Targeted Oncology is published by Springer Paris. The publication country of this journal is France.


What is the abbreviation of Targeted Oncology?

This standard abbreviation of Targeted Oncology is Target. Oncol..


Is "Targeted Oncology" a Journal, Conference or Book Series?

Targeted Oncology is a journal published by Springer Paris.


What is the scope of Targeted Oncology?

The scope of Targeted Oncology is as follows:

  • Oncology
  • Pharmacology (medical)
  • Cancer Research

For detailed scope of Targeted Oncology, check the official website of this journal.


What is the ISSN of Targeted Oncology?

The International Standard Serial Number (ISSN) of Targeted Oncology is/are as follows: 1776260X, 17762596.


What is the best quartile for Targeted Oncology?

The best quartile for Targeted Oncology is Q1.


What is the coverage history of Targeted Oncology?

The coverage history of Targeted Oncology is as follows 2006-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/
  • Issn.org, https://www.issn.org/
  • Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.


Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series


Journal/Conference/Book Title Type Publisher Ranking SJR h-index Impact Score
Zeitschrift fur Germanistische Linguistik Journal De Gruyter Mouton 22945 15 0.19
Analysis in Theory and Applications Journal Springer Netherlands 19346 11 0.00
IEEE/OSA Journal of Display Technology Journal IEEE Computer Society 12809 68 0.00
CESifo Economic Studies Journal Oxford University Press 14012 32 1.70
Journal of Education and Work Journal Brill Academic Publishers 9268 43 1.93
British Journal of Special Education Journal Wiley-Blackwell Publishing Ltd 12024 42 1.24
Transnational Corporations Journal UNCTAD United Nations Conference on Trade and Development 6120 27 1.92
Howard Journal of Communications Journal Taylor and Francis Ltd. 9564 36 1.66
Exploration Geophysics Journal Taylor and Francis Ltd. 16383 48 1.17
Biological Procedures Online Journal BioMed Central Ltd. 3350 43 6.40

Check complete list




Targeted Oncology Impact Score (IS) Trend

Table: Impact Score

Year Impact Score (IS)
2023/2024 Updated Soon
2022 4.79
2021 4.65
2020 3.91
2019 3.89
2018 3.73
2017 3.68
2016 3.03
2015 2.89
2014 3.73



Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Cancer Discovery
American Association for Cancer Research Inc. | United States

Lancet Regional Health - Europe, The
Elsevier Ltd. | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of Thoracic Oncology
International Association for the Study of Lung Cancer | United States

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

See All

Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

npj Vaccines
Nature Publishing Group | United Kingdom

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Wiley-Blackwell Publishing Ltd | United Kingdom

Journal of Biomedical Science
BioMed Central Ltd. | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

Drugs
Adis International Ltd | United Kingdom

Rheumatology
Oxford University Press | United Kingdom

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

Vaccines
Multidisciplinary Digital Publishing Institute (MDPI) | Switzerland

BioDrugs
Adis International Ltd | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

European Heart Journal - Cardiovascular Pharmacotherapy
Oxford University Press | United Kingdom

Drug and Alcohol Dependence
Elsevier Ireland Ltd | Ireland

See All

Top Journals/Conferences in Cancer Research

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Cell Host and Microbe
Cell Press | United States

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

Signal Transduction and Targeted Therapy
Springer Nature | United Kingdom

Journal of Hematology and Oncology
BioMed Central Ltd. | United Kingdom

Journal of the National Cancer Institute
Oxford University Press | United Kingdom

Neuro-Oncology
Oxford University Press | United Kingdom

Clinical Cancer Research
American Association for Cancer Research Inc. | United States

Annual Review of Cancer Biology
Annual Reviews Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United States

Trends in Cancer
Cell Press | United States

See All